In addition, when the expression of NRXN3 in an individual decreases, the risk of Alzheimer’s disease increases, but its underlying mechanism needs to be further elucidated (Zheng et al., 2018). Here, NRXN3 is linked to early-onset autosomal dominant Alzheimer disease.